Policy & Politics
Access to Lifesaving Generic Medicines Threatened by U.S. Trade Pact
September 9, 2011
"Access to affordable lifesaving medicines will be threatened where they are needed most -- in parts of the developing world -- if the U.S. insists on implementing restrictive intellectual property policies in the Trans-Pacific Partnership (TPP) trade agreement," states a press release from Doctors Without Borders. According to the release, "a leaked draft of the U.S. position indicates that the U.S. Trade Representative (USTR) is demanding aggressive intellectual property provisions that go beyond what international trade law requires" and that these measures would "delay the introduction of more affordable generic drugs" (9/8).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)